Valuation: AddLife AB

Market Cap 19.19B 1.98B 1.74B 1.62B 1.48B 2.79B 191B 2.83B 7.5B 93.69B 7.43B 7.27B 324B P/E 2026 *
35.9x
P/E 2027 * 28.3x
Enterprise Value 22.78B 2.35B 2.06B 1.92B 1.76B 3.31B 226B 3.36B 8.9B 111B 8.82B 8.63B 384B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.9x
Free-Float
90.8%
Yield 2026 *
1.07%
Yield 2027 * 1.31%
3 months+98.36%
6 months+98.36%
Current year+98.36%
Current year 15.75
Extreme 15.75
15.75
1 year 15.75
Extreme 15.75
15.75
3 years 15.75
Extreme 15.75
15.75
5 years 7.94
Extreme 7.94
42
10 years 7.94
Extreme 7.94
42
Manager TitleAgeSince
Chief Executive Officer 54 2021-12-31
Director of Finance/CFO 56 2021-12-31
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 59 2015-03-04
Director/Board Member 57 2014-12-31
Director/Board Member 62 2014-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.98B
+2.29%+2.36%-17.97%-10.09% 180B
+1.46%+0.01%-9.87%-6.25% 107B
+1.58%+0.65%+6.69%+61.86% 60.29B
-1.13%-2.60%+26.37%+54.76% 50.19B
+2.22%-1.14%-14.85%-44.15% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-17.52%-43.99% 27.61B
-7.67%-8.39%+17.59%-12.73% 23.1B
+1.63%-1.73%-5.80%-7.80% 20.86B
Average +0.49%-2.24%-1.92%-1.05% 60.44B
Weighted average by Cap. +1.28%-0.40%-6.63%+0.84%

Financials

2026 *2027 *
Net sales 10.9B 1.12B 987M 918M 843M 1.58B 108B 1.61B 4.26B 53.22B 4.22B 4.13B 184B 11.62B 1.2B 1.05B 978M 898M 1.69B 115B 1.71B 4.54B 56.71B 4.5B 4.4B 196B
Net income 535M 55.11M 48.41M 45.02M 41.31M 77.62M 5.31B 78.81M 209M 2.61B 207M 202M 9.02B 679M 70.01M 61.49M 57.19M 52.48M 98.6M 6.74B 100M 265M 3.31B 263M 257M 11.46B
Net Debt 3.59B 370M 325M 302M 277M 521M 35.63B 529M 1.4B 17.52B 1.39B 1.36B 60.56B 2.91B 300M 264M 245M 225M 423M 28.93B 430M 1.14B 14.22B 1.13B 1.1B 49.17B
Logo AddLife AB
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Employees
2,360
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
157.50SEK
Average target price
198.33SEK
Spread / Average Target
+25.93%

Quarterly revenue - Rate of surprise